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Abstract
The 43 kDa subunit of the chloroplast signal recognition particle, cpSRP43, is an ATP-independent chap-
erone essential for the biogenesis of the light harvesting chlorophyll-binding proteins (LHCP), the most
abundant membrane protein family on earth. cpSRP43 is activated by a stromal factor, cpSRP54, to more
effectively capture and solubilize LHCPs. The molecular mechanism underlying this chaperone activation
is unclear. Here, a combination of hydrogen–deuterium exchange, electron paramagnetic resonance, and
NMR spectroscopy experiments reveal that a disorder-to-order transition of the ankyrin repeat motifs in
the substrate binding domain of cpSRP43 drives its activation. An analogous coil-to-helix transition in
the bridging helix, which connects the ankyrin repeat motifs to the cpSRP54 binding site in the second
chromodomain, mediates long-range allosteric communication of cpSRP43 with its activating binding part-
ner. Our results provide a molecular model to explain how the conformational dynamics of cpSRP43
enables regulation of its chaperone activity and suggest a general mechanism by which ATP-
independent chaperones with cooperatively folding domains can be regulated.
 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creati-
vecommons.org/licenses/by-nc-nd/4.0/).IntroductionCells employ a diverse network of chaperones to
assist in a variety of processes needed to maintain
protein homeostasis, including de novo protein
folding, sequestration and remodeling of
misfolded proteins, and localization to target
cellular compartments. To precisely time the
capture, folding, and release of their substrates,
chaperones undergo controlled structural
rearrangements to complete their functional cycle.
Many chaperones, such as members of the
ubiquitous Hsp70, Hsp90, and Hsp100 families,
use regulated ATPase cycles to alternate
between conformations that promote clientrs. Published by Elsevier Ltd.This is an open accapture or release and even to remodel client
conformations during this cycle.1–3 Many ATP-
independent small heat shock proteins undergo
changes in oligomeric state and/or unfolding transi-
tions upon activation under stress conditions.4–7
A distinct group of chaperones are dedicated to
the post-translational targeting of integral
membrane proteins, and their chaperone cycle
needs to be spatially regulated. Membrane
proteins contain hydrophobic transmembrane
domains (TMDs) that are highly prone to
misfolding and aggregation in the aqueous
environments where they are initially synthesized.cess article under the CC BY-NC-ND license (http://creativecommons.org/
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effective molecular chaperones to protect them
from aggregation, maintain them in an insertion-
competent state, and guide them to the
appropriate cellular membrane. Many examples
illustrate the intimate link between chaperone
function and membrane protein biogenesis: SecB,
Skp and SurA protect bacterial outer membrane
proteins,8–14 and components of the GET and
SND pathways deliver membrane proteins harbor-
ing late TMDs.15,16 A conserved feature of mem-
brane protein chaperones is that they need to turn
‘on’ in the aqueous phase to tightly capture and pro-
tect membrane protein clients, and to turn ‘off’ at the
target membrane to facilely release clients for mem-
brane insertion. Failure to properly protect mem-
brane proteins leads to the formation of toxic
aggregates and is implicated in a variety of neurode-
generative disease pathologies.17 Despite their
importance, only a few membrane protein chaper-
one systems have been studied in detail, and the
regulatory mechanism of most membrane protein
chaperones remain not well understood.
The light harvesting chlorophyll-binding proteins
(LHCPs) in green plants comprise ~50% of the
proteins in the thylakoid membrane and are the
most abundant family of membrane proteins on
earth.18 Like the vast majority (>95%) of organellar
proteins, LHCPs are translated in the cytosol and
imported into the chloroplast stroma, where they
form a soluble “transit complex” with the chloroplast
signal recognition particle (cpSRP) comprised of
cpSRP43 and cpSRP54 subunits.19–22 Via the
interaction of cpSRP54 with the membrane-bound
receptor, cpFtsY, the transit complex is recruited
to the thylakoid membrane and hands off LHCP
to the Alb3 translocase.23–29 Alb3 mediates the
insertion of LHCPs into the membrane, where they
assemble into the light harvesting complex that
forms the antenna of the photosynthetic reaction
center.18,30 The abundance of LHCPs and their
crucial roles in energy generation of green plants
necessitate highly effective chaperones to assist
in their biogenesis, making it a robust system to
understand the function and mechanism of mem-
brane protein chaperones.
The cpSRP43 subunit in cpSRP is responsible for
chaperoning LHCPs during their targeted delivery
to the thylakoid membrane.31,32 cpSRP43 contains
a substrate binding domain (SBD) consisting of four
ankyrin repeat motifs capped by an N-terminal chro-
modomain (CD1) and a C-terminal bridging helix
(BH).32–34 The ankyrin repeat motifs in the SBD rec-
ognize a conserved L18 motif between TMD2 and
TMD3 of LHCP.22,33–36 The SBD also forms exten-
sive contacts with all three TMDs in LHCP, poten-
tially via hydrophobic surfaces on the ankyrin
repeat motifs and the BH, to protect them from
aggregation.37 The chaperone activity of the
cpSRP43 SBD is regulated by interaction partners
that bind at two additional chromodomains2
C-terminal to the SBD. Wildtype cpSRP43 displays
lower chaperone activity than the SBD, but is acti-
vated upon binding of a motif from the C terminus
of the cpSRP54 M-domain (54 M) to CD2.38–40 In
contrast, the stromal domain of the Alb3 translo-
case binds to CD3 and triggers the selective release
of the LHCP TMDs from cpSRP43.34 These regula-
tions in chaperone activity strongly correlated with
changes in the HSQC spectra of cpSRP43. At least
two component peaks were observed for multiple
residues in CD1 in apo cpSRP43. One of the com-
ponent peaks became dominant under activating
conditions, such as in the isolated SBD or upon
addition of the 54 M or L18 peptide, whereas the
opposite component peak became dominant in
the presence of the Alb3 stromal domain.34 These
observations led to a model in which free cpSRP43
samples both a chaperone-inactive, open state and
a chaperone-active, closed state. cpSRP54 drives
cpSRP43 to the closed state to enable effective
capture of LHCPs in the stroma, whereas the Alb3
translocase drives its transition to the open state
to effect the facile release of LHCPs at the site of
membrane insertion.
Despite this conceptual framework, the nature of
the conformational changes underlying cpSRP43
activation remains poorly understood. Due to
crowding of the HSQC spectra, component cross
peaks for both the open and closed states of
cpSRP43 could be assigned for only 12 residues
in CD1, whereas only the peaks for the closed
state were assigned for the majority of residues in
the SBD.34 Crystal structures are available for the
SBD and SBD-CD2 fragments bound to the 54 M
peptide, which primarily capture the closed confor-
mation.38,41 A complete picture of cpSRP430s con-
formational landscape throughout its chaperone
cycle is therefore lacking. To address this gap in
knowledge, we used a combination of biophysical
approaches, including hydrogen–deuterium
exchange (HDX), electron paramagnetic reso-
nance (EPR) and NMR spectroscopy, to probe
the structural changes of cpSRP43 during its acti-
vation. Our results show that the ankyrin repeat
motifs and the BH of cpSRP43 undergo a
disorder-to-order transition, whereas CD1 shifts
between two folded structures during the open-to-
closed rearrangement. We propose a model in
which a coil-to-helix transition in the BH is propa-
gated across the ankyrin repeat domain of
cpSRP43 and allows long-range communication
of the activating ligand to drive folding of the sites
required for substrate binding.Results
The cpSRP43 SBD is better solvent-protected
in the activated state
To probe for potential structural changes in the
cpSRP43-SBD during its activation, we compared
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efficiencies between free cpSRP43 and cpSRP43
bound to a peptide containing its recognition motif
on LHCP (L18) or on the M-domain of SRP54
(54M peptide; Figure 1). HDX coupled to mass
spectrometry (MS) measures the local solvent
accessibility of amide protons, which vary the
most at sites of protein–protein interactions or
sites undergoing largescale conformational
changes.42 Over 160 peptides were observed and
analyzed from each MS spectrum of cpSRP43,
covering >90% of its protein sequence across all
domains (Figures S1–S4). Many regions of
cpSRP43 (CD1, ankyrin repeat motifs, BH, CD3,
and the C terminus of CD2) were identified by mul-
tiple peptides, providing redundant data that ensure
reliable and accurate quantification.
We found that both the L18 and 54 M peptides
induced slower H/D exchange of backbone
amides in ankyrin repeat motifs 1–4 and the BH
in the SBD of cpSRP43 (Figures 1(a), (b) and
S1–S2). In general, the 54 M peptide had a larger
effect than L18 in reducing the rate of H/D
exchange. Additional sites in CD2 also showed
significantly lower HDX in the presence of 54 M
(Figures 1(b) and S2), presumably due to
shielding of the 54 M binding site from solvent
and possibly 54 M-induced local rearrangements
in CD2. Although ligand-induced protection from
H/D exchange could arise from either shielding ofFigure 1. Substrate, activating ligand, and activating muta
SBD from solvent exchange as determined by HDX mas
(Figures S1–S4) relative to wildtype, apo-cpSRP43 are ma
bound cpSRP43 (a); 54 M-bound cpSRP43 (b); superactive
(reduced solvent exchange) or deprotection (increased solve
and gray denotes no change. 3the ligand binding site or from induced
conformational changes, the reduction in solvent
accessibility was observed across almost all the
helices in the SBD and includes regions that are
remote from the immediate L18 or 54 M binding
sites. These results suggest that binding of the
substrate (L18) and activator (54 M) induce global
changes in the structure or dynamics of
cpSRP43-SBD that render this domain better
solvent protected.
To directly test this model, we analyzed the H/D
exchange profile of two previously identified
superactive cpSRP43 mutants that are pre-
organized into the active conformation: cpSRP43
(intein), in which the short Gln-Val linker between
the BH and CD2 was replaced by a longer and
more flexible sequence; and cpSRP43-SBD, a
construct containing only the SBD but lacking
CD2 and CD3.34 Both mutants exhibit higher chap-
erone activity than wildtype cpSRP43, are predom-
inantly in the active state based on HSQC NMR
data, and largely bypass activation by cpSRP54.34
HDX analyses showed that, compared to wildtype
cpSRP43, significant reductions in backbone sol-
vent accessibility across the entire SBD, including
the ankyrin repeat motifs and the BH (Figures 1
(c), (d), S3 and S4), were observed with both
mutants. In contrast, few changes in HDX effi-
ciency were observed in CD1, CD2 and CD3
between these mutants and wildtype cpSRP43tions lead to increased global protection of the cpSRP43
s spectrometry. The differences in HDX incorporation
pped onto the structure for the following samples: L18-
cpSRP43(intein) (c); and cpSRP43-SBD (d). Protection
nt exchange) are denoted by pseudo-colors as indicated,
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the SBD observed with the superactive chaperone
mutants were similar to those induced by 54 M and
L18, although 54 M induced the strongest protec-
tions. Together, these results indicate that the
SBD of cpSRP43, specifically the ankyrin repeats
and BH, becomes better solvent protected in the
activated state.
Substrate and activator rigidify the cpSRP43
SBD
To gain higher resolution information into the
substrate and 54 M-induced structural changes in
cpSRP43-SBD, we used site-directed spin
labeling and electron paramagnetic resonance
(EPR) spectroscopy, which provides a sensitive
probe for the local backbone mobility at sites of
interest. The nitroxide probe (1-oxy-2,2,5,5-tetrame
thyl-3-pyrrolinyl-3-methyl) methanethiosulfonate
(MTSSL) is small with a short spacer, which can
be placed throughout a protein without
significantly affecting structure.43 The mobility of
MTSSL is highly dependent on the local secondary
or tertiary structure,44 which can be used to distin-
guish loops from helices and sites on the surface
from those buried in the protein interior.45,46 Using
a previously characterized cysteineless cpSRP43
mutant that retains chaperone activity within 2–3
fold of wildtype cpSRP43 and is strongly activated
by 54 M (37 and Figure S5), we introduced single
cysteine mutations at selected residues in the
SBD where the mutation affected chaperone activ-
ity less than three-fold (Figure 2(a) & (b) and 37).
The native cysteine (C175) and the engineered sin-
gle cysteines allowed site-specific labeling with
MTSSL. We verified that the MTSSL-labeled
cpSRP43 could still bind the 54 M peptide with
affinities that are within 3-fold of WT cpSRP43 (Fig-
ure S5(a) and 38) and that 54 M binding restored full
chaperone activity of MTSSL-labeled cpSRP43
variants towards LHCP (Figure S5(b) & (c)). We
measured the effects of 54 M and the substrate
protein, LHCP, on the EPR spectra of spin-
labeled cpSRP43. The changes in the EPR spectra
were characterized by the linewidth of the central
resonance (Figure 2(c) and (d), DH0) and the over-
all breadth of the EPR spectra, especially the inten-
sity of hyperfine splitting that arises from highly
immobile populations of spin probes relative to
the mobile population (Figure 2(c)).47–49
All five spin labels in the ankyrin repeat motifs
and the BH (C175, R192C, V205C, I253C,
G264C) underwent significant EPR spectral
changes upon binding the 54 M peptide and/or
LHCP (Figure 2(c) and (d), black vs. red and
green). Four of the spin probes at these positions
become less mobile, as reflected by an increase
in the central linewidth and the reductions in the
mobile fraction in the EPR spectra (Figure 2(c)
and (d)). For the remaining residue, R192C,
changes in probe mobility were not obvious from4
the central linewidth but were readily detectable
from changes in EPR spectral shape upon the
addition of both 54 M and LHCP, which showed a
higher relative population of immobile species
(Figure 2(c)). As 54 M binds outside the SBD
(Figure 1), the observed immobilization of multiple
spin probes indicates long-range allosteric
communications propagated throughout the
ankyrin repeat domain. On the other hand, none
of the four spin probes in CD1 underwent
significant spectral changes upon binding of 54 M
or LHCP (Figure 2(c) and (d)). Collectively, the
EPR data show that the 54 M- and substrate-
induced conformational changes in the cpSRP43-
SBD lead to increased backbone rigidity of the
ankyrin repeat domain and the BH, but these
changes did not propagate to CD1.
NMR spectroscopy reveals disorder-to-order
transitions in the SBD
To obtain dynamic information on the changes in
the cpSRP43-SBD during its activation, we
employed site specific fluorine-labeling and NMR
spectroscopy. We attached the 3-bromo-1,1,1-tri
fluoropropan-2-one (BTFA) probe to single
cysteines engineered at surface-exposed residues
throughout cysteineless cpSRP43 and collected
1D 19F NMR spectra (Figure 3(a)). To test
whether cysteine mutation and BTFA-labeling
disrupted the activity or activation of cpSRP43,
we measured the ability of each BTFA-labeled
cpSRP43 variant to prevent LHCP aggregation
with and without 54 M present using light
scattering assays (Figure S6). Only the variants
that retained chaperone activity and could be
activated by 54 M were subjected to further NMR
analysis.
Most cpSRP43 variants labeled with a single
BTFA probe produced spectra with two or more
peaks. The spectra were deconvoluted into
individual component peaks, which allowed us to
extract three fitting parameters for each peak: the
chemical shift, peak width, and peak area
(Figures 3(b) and S7). With the exception of
residue L363C (in CD3), addition of the activating
peptides, 54 M or L18, changed the relative
abundance of the component peaks at most
BTFA labeled sites (Figure 3(c) and (d)), whereas
the chemical shifts of each component peak
remained largely unchanged (Figure S7). This
supports the model that interaction partners
stabilize specific conformational states that are
already sampled by apo cpSRP43.34 We assigned
the component peaks that increased in relative
abundance in response to L18 or 54 M to the
chaperone-active closed conformation, and those
that decreased in abundance upon L18 and 54 M
binding to the chaperone-inactive open conforma-
tion (Figure 4(a)). In contrast to most probes in
the SBD, we detected only one peak for the BTFA
probe in CD3 (L363C) that was unchanged upon
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observations from amide HSQC data that CD3
does not sense or respond to 54 M or L18 bind-
ing.34 Finally, 19F Diffusion Ordered Spectroscopy
(DOSY) measurements on apo cpSRP43 D150C-
BTFA showed nearly identical diffusion coefficients
for the two component peaks (7  107 cm2 s1,
Figure S8), excluding the possibility that one of
the peaks arises from oligomerization.50 The ability
to observe both conformations of cpSRP43 in 19F
NMR allowed us to directly extract information
about the structural changes during its activation.
We first compared the chemical shifts of 19F-
BTFA labeled cpSRP43 between the closed and
open conformations, which provide information on
the local environment of the BTFA probes. The
19F peaks for probes in Ank1, Ank3 and Ank4
(D150C, E211C, E221C, and E236C) shifted
significantly upfield in the open conformation
compared to the closed conformation (Figures S7
and S9), suggesting that these sites are more
solvent exposed in the open conformation.51,52
The 19F peaks for the probe in the BH (I253C)
showed the opposite change; however, the com-
plexity of the 19F spectra for I253C-BTFA suggests
the presence of additional interactions or conforma-
tional states that complicate interpretation of its
chemical shift values. Importantly, the component
peaks for the closed conformation are well dis-
persed across all the BTFA probes in the ankyrin
repeat motifs and the BH (Figures S7 and 3(d),
blue circles). In contrast, the open conformation
peaks for probes in the first three ankyrin repeats
are narrowly dispersed around 84.4 ppm (Figures
S7 and 3(d), red circles). This strongly suggests
that, in contrast to the well-folded, closed confor-
mation of cpSRP43 in which each BTFA probe is
in a unique chemical environment, many sites in
the ankyrin repeat motifs and the BH are partially
disordered in the open conformation.
To identify changes in protein dynamics upon
ligand-induced activation of cpSRP43, we
compared the peak widths of the BTFA probes
between the open and closed conformations. In
the closed state, the 19F linewidths are relatively
uniform for the apo cpSRP43 and its complexes
with 54 M and L18 (Figures S7, 4(b) and (c)). ForFigure 2. The cpSRP54 M-domain and substrate induce
domain and the BH of cpSRP43. (a) Structure of the cpS
analyses. (b) The chaperone activities of single cysteine cpS
Reactions used 1 mM LHCP and 2.5 mM WT or mutant cp
cpSRP43(C175A, C297S), which is denoted as WT. (c) EP
cpSRP43 (black), cpSRP43 bound to 54 M (red), and cpSRP
show a zoom-in of the spectra at 3450–3475 G, which co
populations of the spin probe. (D) Summary of the effects o
spectra for spin labels at various positions in the SBD, quan
mean ± S.D., with n  2.
6
all BTFA probes in the ankyrin repeat motifs and
the BH, the 19F peaks corresponding to the open
conformation are significantly broader than those
for the closed conformation (Figure 3(d) and (e)).
This suggests conformational fluctuations in the
open state on the ls–ms time scale53 and is con-
sistent with the evidence from HDX and EPR that
the SBD in apo cpSRP43 is flexible and becomes
more rigid upon binding of L18 or 54 M. The great-
est broadening was observed for BTFA probes in
Ank3, Ank4, and the BH (E221C, E236C, and
I253C; Figure 4(c)), suggesting that the C-
terminal half of the SBD is particularly flexible in
the open conformation. These observations of
structural disorder are analogous to the findings
with IKBa,54,55 Notch,56,57 and p19(INK4d),58, and
appear to be a conserved feature among ankyrin
repeat domain proteins.59 In contrast, the compo-
nent peaks for both the open and closed conforma-
tions have similarly narrow peak widths for BTFA
probes in CD1 (Y119C) (Figure 3(d) and (e)), sug-
gesting that CD1 is well-folded in both states.
To obtain additional evidence for a disorder-to-
order transition during the open-to-closed
rearrangement in cpSRP43, we tested the effect
of urea on the 1H, 15N-HSQC TROSY spectra of
apo cpSRP43. If the open state is partially
disordered and the closed state is fully folded,
denaturant should shift the equilibrium towards
the open state. Previous HSQC NMR studies of
cpSRP43 identified 12 residues in CD1 that show
two component cross peaks; the change in their
relative abundance upon addition of L18 and
54 M peptide further allowed the assignment of
the peaks to the open or closed conformation.34
Intriguingly, titration of low doses of urea (up to
0.4 M) significantly reduced the component cross
peaks for the closed conformation, with a corre-
sponding increase in the intensity of the component
cross peak for the open conformation (example for
S92 shown in Figure 4(a) and (b)). The same
reduction was observed for all the residues in
CD1 for which component cross peaks could be
confidently assigned (Figure 4(c)). These results
show that denaturant such as urea promotes the
open conformation in cpSRP43 and moreover, that
the closed conformation of cpSRP43 is only mar-immobilization of spin probes across the ankyrin repeat
RP43 SBD highlighting residues used for SDSL-EPR
RP43 mutants were analyzed using the turbidity assay.
SRP43. All comparisons were relative to cysteineless
R spectra for spin labels at indicated positions in apo-
43 bound with both 54 M and LHCP (green). The insets
ntain the peaks reporting on the mobile and immobile
f 54 M and LHCP on the central line width (DH0) of the
tified from the data in part C. All values are reported as
Figure 3. Analysis of the19F NMR spectra of BTFA-labeled cpSRP43. (a) Composite structural model of cpSRP43
based on the coordinates for SBD-CD2 (PDB: 3UI2) and CD2-CD3 (PDB: 5E4W). BTFA terminal carbons are shown
as labeled spheres. The individual domains are colored to match the diagram in C. Interacting peptides from binding
partners (L18, 54 M) are indicated. (b) Example of a deconvolution of the 19F spectrum for E236C-BTFA, with the
experimental data in black, individual component peaks in blue, and the sum of the component peaks in red. Three
parameters can be extracted: the chemical shift of the peak center (ppm), the peak width (ppm), and the peak area.
(c) Summary of the relative abundance of component cross peaks for the indicated BTFA probe sites in apo
cpSRP43, cpSRP43 + 54 M, and cpSRP43 + 54 M + L18, calculated from deconvolution of the 19F NMR spectra for
BTFA shown in (b). (d) Comparison of the chemical shift and peak width for component cross peaks for the closed
(blue circles) and open (red circles) conformations in apo cpSRP43 (left), cpSRP43 bound to 54 M peptide (middle),
and cpSRP43 bound to both the 54 M and L18 peptides. The size of the circle indicates the relative abundance of the
component peak. (e) Summary of the line widths of the 19F resonances in the closed (blue) and open (red)
conformations of apo cpSRP43 for the indicated BTFA-labeled sites. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
A. Siegel, C.Z. McAvoy, V. Lam, et al. Journal of Molecular Biology 432 (2020) 166708
7
Figure 4. Low doses of urea drive cpSRP43 into the open state. (A) Effect of urea on the relative intensity of the
component cross peaks for Ser92 in the TROSY spectra of 2H, 15N-labeled apo cpSRP43. (B) Quantification of the
data in part A. (C) Summary of the effects of urea on the relative intensities of the open conformation cross peaks at
the indicated residues. Relative intensities were determined from cross peak heights. (D) 19F 1D NMR spectra on
BTFA-labeled apo cpSRP43 at 0 M (green), 0.5 M (blue), 1 M (purple), and 6 M (yellow) urea. The assigned peaks are
labeled by conformation: closed (c), open 1 (o1), open 2 (o2), and unfolded (u). (E) Relative populations of closed
(blue), open 1 (red), and open 2 (pink), and unfolded (gray) peaks at the indicated urea concentrations. (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
A. Siegel, C.Z. McAvoy, V. Lam, et al. Journal of Molecular Biology 432 (2020) 166708ginally more stable than the open conformation and
can therefore be substantially destabilized by low
doses of denaturant.
To further probe the conformational changes in
the ankyrin repeat motifs, whose open
conformation cross peaks could not be assigned
in the 1H, 15N-HSQC TROSY spectra, we
collected 19F NMR spectra on BTFA-labeled apo8
cpSRP43 at increasing urea concentrations.
Addition of 0.5–1 M urea reduced the component
peak for the closed conformation, with a
corresponding increase in the open conformation
peaks for the BTFA probes in CD1 (Y119C) and
Ank2–4 (D150C, E221C, E236C) (Figure 4(d) and
(e)), consistent with the effect of urea on the
HSQC spectra (Figure 4(a) and (b)). As described
A. Siegel, C.Z. McAvoy, V. Lam, et al. Journal of Molecular Biology 432 (2020) 166708earlier, the open state peaks for BTFA probes in
Ank3 (E221C) and Ank4 (E236C) were broad
(Figure 4(c)) and suggested the presence of
multiple conformations in intermediate exchange.
In support of this model, multiple component
peaks with narrower widths were observed for the
open state in the presence of 0.5–1 M urea
(Figure 4(d) and (e); ‘o1’ and ‘o2’), suggesting
that urea accelerated the exchange between
multiple conformations with different degrees of
solvent exposure in the open state. For BTFA
probes in the ankyrin repeat motifs, the
component peaks for the open state also shifted
upfield at 0.5–1 M urea (Figure 4(d)), in contrast
to the solvent effect of urea that shifts the 19F
peaks downfield in general (see Fig. S10 for the
effect of urea on a BTFA-labeled peptide, and
Figure 4(d) for the effect of urea on the closed
state peaks), suggesting that urea enhanced the
solvent exposure of the open conformations at
these sites.60,61 Finally, while the BTFA probes in
the Ankyrin repeat domain were completely
unfolded in 6 M urea, only 35% of the probe in
CD1 (Y119C) was unfolded in 6 M urea (Figure 5
(d) and (e)), indicating that CD1 is stably folded in
the open state. Together, these results provide
additional evidence that the ankyrin repeat motifs
exchange between multiple partially unfolded con-
formations in the open state.
In summary, 19F NMR allowed us to directly
observe both the open and closed conformations
in cpSRP43 and detect widespread disorder and
flexibility in the ankyrin repeat motifs and the BH
in the open conformation compared to the well-
structured closed state. These results support
findings from the H/D exchange and EPR data
and provide direct evidence that the open-to-
closed rearrangement of cpSRP43 involves
widespread changes across the SBD, with the
ankyrin repeat motifs and BH undergoing a
disorder-to-order transition and CD1 rearranging
from one well-folded structure to another.
A folded bridging helix is essential for
chaperone activity
To test if rearrangement to a well-folded ankyrin
repeat domain is required for chaperone activity,
we re-examined the effects of several mutations
in the BH, which serves as a C-terminal capping
element for the ankyrin repeat domain of
cpSRP43 and bridges the ankyrin repeat motifs to
the cpSRP54 binding site in CD2 (Figure 5(a)).
The BH is essential for maintaining the closed
state of cpSRP43, and its deletion abolishes the
chaperone activity of cpSRP43-SBD towards
LHCP,34 indicating its critical role in cpSRP43 func-
tion. Multiple mutations in the BH have been intro-
duced that disrupt either intra- or inter-helical
contacts. The side chains of R252 and E256 form
an (i, i + 4) salt bridge that stabilizes helix formation
in the BH. I259 and E262 engage in close contacts9
with residues from the neighboring helix in Ank4
that stabilize inter-helical packing (Figure 5(a)).
Mutation of any of these residues severely dis-
rupted cpSRP430s chaperone activity (Figure 5(b–
d), Supplementary Table 1; see also 37). In con-
trast, mutations of I253 and G264, which extend
out towards the solvent in the closed conformation
structure, did not substantially affect chaperone
activity (Figure S6 and 37). The R252C, E256C,
I259C and E262C mutations caused large deleteri-
ous effects on chaperone activity even with
cpSRP43-SBD, in which CD2 and CD3 have been
deleted (Figure 5(f)), excluding models in which the
mutational defects are caused by disruption of
interactions between the BH and the nearby chro-
modomains. Thus, a properly folded BH is essen-
tial to arrange the cpSRP43-SBD into an active
conformation, and any disruption of intra- or inter-
helical interactions in the BH have strong deleteri-
ous effects on its chaperone activity.
To provide additional evidence for this model, we
tested the effect of 54 M on these chaperone-
deficient BH mutants. In the absence of 54 M,
none of them effectively suppressed the
aggregation of LHCP, whereas LHCP was close
to completely solubilized by these chaperone
mutants in the presence of 54 M (Figure 5(b) and
(c), summarized in (d) and (e)). Deletion of the
conserved C-terminal basic residues in 54 M,
which disrupts the binding of 54 M with
cpSRP43,62 abolished the rescue of chaperone
activity (Figure 5(b), blue line), supporting the
specificity of this effect. Further, 54 M peptide
was sufficient to produce the same rescue as the
intact 54 M domain (Figure 5(b), red vs. orange
lines), excluding the possibility that the 54 M
domain contributed additional interaction sites for
binding and solubilization of LHCP as previously
proposed.19 Thus, 54 M was able to completely
rescue deleterious mutations that severely disrupt
helix formation in the BH and the chaperone activity
of cpSRP43. The more extensive rescue of the
loss-of-function BH mutants compared to wildtype
cpSRP43 is consistent with a model in which
helix-destabilizing mutations shifted the conforma-
tional equilibrium of cpSRP43 further towards the
open conformation, and are therefore more depen-
dent on cpSRP54 for attaining the chaperone-
active, closed conformation.Discussion
cpSRP43 is a small, ATP-independent
chaperone that captures LHCPs imported into the
chloroplast, protects them during their transit
through the stroma, and delivers them to the
translocation machinery for insertion into the
thylakoid membrane.20 Its small size, robust activ-
ity, well-characterized cellular role, and amenability
to structural methods make it an excellent system
to study the structure-dynamics-function relation-
Figure 5. Disruption of intra- and inter-helical contacts in the bridging helix compromises chaperone activity and
renders cpSRP43 more dependent on cpSRP54. (a) Structure of the SBD-CD2 fragment of cpSRP43 highlighting the
residues in the BH subject to mutational analyses. Colors indicate different mutational effects on the chaperone
activity of cpSRP43. (b) Time courses for the aggregation of LHCP, monitored by turbidity at 360 nm, upon dilution
into buffer (green) or into solutions containing mutant cpSRP43(I259C) in the absence (black) and presence of the
indicated regulatory factors: 54M (red); 54M peptide (orange); mutant 54M lacking the basic C-terminal residues that
bind cpSRP43 (54M(DRRKRK); blue). (c) Time courses for aggregation of LHCP upon dilution into buffer (green), or
into solutions containing mutant cpSRP43(E256C) in the absence (black) and presence (red) of the cpSRP54 M-
domain. (d, e) Summary of the chaperone activities of indicated BH mutants in the absence (d) and presence (e) of
the cpSRP54 M-domain, quantified from the degree of solubilization of LHCP at the indicated chaperone
concentrations based on turbidity measurements. (f) Mutations in the BH disrupt chaperone activity even in the
absence of CD2 and CD3. All mutations were constructed in cysteinless cpSRP43 (C175A, C297S), which is denoted
as WT in this figure.
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work demonstrated that the chaperone activity of
the cpSRP43 SBD is extensively regulated by bind-
ing of cpSRP54 in the stroma and the Alb3 translo-
case at the thylakoid membrane to effect spatial
regulation of its coupled chaperone and protein tar-10geting cycle34. In this work, we employed EPR,
HDX, and NMR spectroscopy to define the struc-
tural changes in cpSRP43 upon its activation. Our
results reveal extensive dynamics in the open con-
formation of cpSRP43 and strongly suggest that a
disorder-to-order transition of the ankyrin repeat
A. Siegel, C.Z. McAvoy, V. Lam, et al. Journal of Molecular Biology 432 (2020) 166708domain is responsible for its activation. Such a
transition provides an attractive mechanism for
long-range molecular communication of the SBD
of cpSRP43 with binding partners that bind in its
CD2 and CD3 domains.
The results of multiple biophysical methods
support a disorder-to-order transition during the
activation of cpSRP43. Under conditions where
cpSRP43 is chaperone-active, either in gain-of-
function variants pre-organized into the closed
state or when it is bound to the 54 M or L18
peptides, we observed substantially reduced
solvent exchange across the entire ankyrin repeat
domain that could not be explained by ligand-
induced shielding, whereas no such changes
were observed in the chromodomains. These
data suggest a global restructuring of the ankyrin
repeat domain during its activation that renders it
better protected from solvent. A clue to the nature
of this structural change was provided by EPR
studies, which showed that paramagnetic probes
across the ankyrin repeat motifs and BH
displayed reduced local backbone mobility upon
substrate or activator binding, whereas those in
CD1 did not change. These results suggest that
the ankyrin repeat domain is structurally more
flexible in the open conformation.
NMR experiments provided direct evidence for
this model. With BTFA probes placed at sites
throughout the SBD, we observed 19F peaks for
both the open and closed conformations of
cpSRP43, showing that these conformers
interconvert slowly on the NMR time scale. For
19F-BTFA probes in the ankyrin repeat domain,
the peaks for the closed state have well
dispersed chemical shift distributions and narrow
peak widths, suggesting a defined three-
dimensional fold consistent with the existing
crystal structures of the cpSRP43 SBD. In
contrast, the open state peaks are poorly
dispersed and become increasingly broad
towards the C terminus of the ankyrin repeat
domain, suggesting a high degree of disorder and
dynamics that explain the HDX and EPR data.
This model is further supported by the
observation that low doses of urea shifts the
conformational equilibrium towards the open
conformation. In contrast to the ankyrin repeat
motifs, both the open and closed state peaks for
19F-BTFA probes in CD1 are well dispersed and
have narrow peak widths. We could further
observe CD1 during the open-to-closed
rearrangement using our assignments of both the
open and closed state peaks for 12 residues in
CD1.34 Despite the chemical shift differences in
the amide HSQC cross peaks of these residues
between the two states,34 the Ca and Cb chemical
shifts of both states are identical, suggesting little
change in the secondary structure of CD1 during
the open-to-closed rearrangement. As these resi-11dues cluster in a pair of b-strands that pack against
Ank1 in the crystal structure of the closed state,
their observed amide chemical shift differences
between the two states likely reflect changes in
the packing of Ank1 against CD1 in the open
state.33 Together, these results indicate that CD1
remains well-folded in both the open and closed
conformations, in agreement with the results from
HDX and EPR analyses. The different effects of
urea on CD1 and the ankyrin repeats in the open
state further support a model where CD1 adopts
a stable fold in both the closed and open states,
whereas the ankyrin repeat domain samples many
partially unfolded conformations with relatively low
stability but is driven to a single, well-folded closed
conformation upon activation. Collectively, all three
biophysical methods show that CD1 remains
folded, while the ankyrin repeat domain undergoes
a disorder-to-order transition during the open-to-
closed rearrangement that activates cpSRP43.
A growing body of work points to the transition
between folded and disordered structures in ATP-
independent chaperones as a general mechanism
to regulate chaperone activity.63 Many of these
chaperones are activated by order-to-disorder tran-
sitions. For example, small heat shock proteins de-
oligomerize and become partially disordered upon
heat stress, which activates them to prevent mis-
folded proteins from aggregation.4,7,64–66 Other
stresses, such as acidic pH or oxidation, trigger
unfolding transitions that activate chaperones such
as HdeA, Hsp33, and Hsp26.5,6,67,68 Our work
shows that the opposite transition is used to acti-
vate cpSRP43, analogous to the Spy13 and Skp11
chaperones that protect nascent membrane pro-
teins during their transit across the bacterial peri-
plasm. The use of a disorder-to-order transition
by cpSRP43 may arise in part from the folding
property of the ankyrin repeat domain, in which
the helices from individual repeats stack together
to form a conserved, concave-shaped scaffold that
presents binding surfaces for target proteins.69 As
interactions within each repeat are less stable than
the interface between repeat motifs, ankyrin repeat
domain proteins fold and unfold cooperatively
despite the lack of long-range tertiary contacts.59
Disorder-to-order transitions have been observed
in IjBa, in which two of the ankyrin repeat motifs
are disordered in the apo protein but becomes
structured upon binding to NFjB,54,55 with the
notch intracellular domain upon binding the CSL
transcription factor,56,57 and with p19(INK4d).58
Importantly, a disorder-to-order transition of the
ankyrin repeat domain provides an attractive
molecular mechanism to explain the long-range
molecular communication of cpSRP43 with
cpSRP54, whose binding in CD2 induces structural
changes that propagate across the entire SBD.
We propose a model in which a disorder-to-order
transition in the ankyrin repeat domain of cpSRP43
Figure 6. Model for allosteric regulation of cpSRP43’s chaperone activity. In the open conformation, the SBD’s
ankyrin repeat domain and BH are flexible and disordered, resulting in an inactive chaperone. The interaction of
cpSRP43 with the cpSRP54 M-domain or with the L18 motif on the LHCP substrate stabilizes the closed
conformation, in which the Ankyrin repeat domain is more stably folded. This rearrangement enables the formation of
contiguous contact surfaces on the cpSRP43-SBD for the substrate TMDs and thus high chaperone activity. The
interaction of cpSRP54 with cpFtsY delivers the transit complex to the Alb3 translocase at the thylakoid membrane,
where Alb3 triggers cpSRP43 to release LHCP and mediates its insertion into the membrane.
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substrate binding (Figure 6). Apo cpSRP43
extensively samples a chaperone-inactive, open
conformation in which the ankyrin repeat domain
is partially disordered and highly dynamic,
especially towards the C-terminal repeat motifs
and the BH. Binding of cpSRP54 in CD2,
adjacent to the BH, induces a coil-to-helix
transition in the BH, enabling it to initiate inter-
repeat interactions that propagate across the
ankyrin repeat domain. This generates a well-
folded, closed conformation in the SBD that
presents both the L18 binding site and contiguous
hydrophobic surfaces needed for efficient capture
of the LHCP TMDs, whereas these contact
surfaces would be disrupted in the partially
unfolded open conformation. We speculate that
other allosteric regulators, such as the Alb3
translocase, could act by inducing additional
conformational transitions in cpSRP43 when the
targeting complex is delivered to the thylakoid
membrane and thus favor selective release of
LHCPs at the site of their membrane insertion.
Materials and methods
Protein expression and purification
Single cysteine mutants of Lhcb5 and cpSRP43
were constructed using the QuikChange
Mutagenesis procedure (Stratagene) according to
manufacturer’s instructions. WT and mutant
cpSRP43, LHCP, and wildtype and mutant Lhcb5
were overexpressed and purified as previously
described.31Aobs ¼ A0 þ DA
54M½  þ cpSRP43½  þ Kd 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð 54M½  þ cpSRP43½ 
q
2  ½54M
12Chaperone activity of cpSRP43
The ability of cpSRP43 to prevent LHCP
aggregation was measured as described
previously.32,36 Aggregates were removed via ultra-
centrifugation in a TLA-100 rotor (Beckman Coul-
ter) at 100,000 rpm for 30 min at 4 C prior to the
experiment. Light scattering experiments were per-
formed by addition of 3 mL of 50 mM LHCP dena-
tured 8 M urea to 150 mL buffer D (50 mM
KHEPES, pH 7.5 and 200 mM NaCl) or 2.5 mM
cpSRP43 in buffer D. Light scattering was moni-
tored at 360 nm on a UV–Vis spectrometer (Beck-
man Coulter) over time until equilibrium was
reached. The percentage of soluble LHCP (% sol-
uble) at equilibrium was plotted for each single-
cysteine cpSRP43 mutant.Measurement of cpSRP54M binding
Experiments were carried out as previously
described.34 Binding of cpSRP43 to the cpSRP54M
peptide (QKQKAPPGTARRKRKAC) was detected
by changes in fluorescence anisotropy of Fluores-
cein labeled on the C-terminal cysteine. Anisotropy
measurements were performed in 50 mM HEPES
(pH 7.5), 200 mM NaCl at 25 C on FluoroLog 3–
22 (Yobin Yvon), using 10 nM fluorescein-labeled
54 M peptide and indicated concentrations of
MTSSL-labeled cpSRP43. The samples were
excited at 500 nm, and the fluorescence anisotropy
was recorded at 527 nm. To obtain the equilibrium
dissociation constant between cpSRP43 and 54 M,
the data were fit to:ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
þ Kd Þ2  ð4  54M½  cpSRP43½ Þ
; ð1Þ
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the anisotropy value of 54 M-fluorescein alone, DA
is the change in anisotropy at saturating
concentrations of cpSRP43, and Kd is the
equilibrium dissociation constant for the
interaction between MTSSL-labeled cpSRP43
and 54 M-fluorescein.Site-directed spin labeling and EPR
measurements
Spin labeling reactions were performed in 50 mM
HEPES (pH 7.5), 200 mM NaCl. Reduced and
degassed single cysteine mutants of cpSRP43
were labeled with a five- to tenfold molar excess
of MTSSL (Toronto Research Chemicals) at room
temperature in the dark for 2–3 h. Excess MTSSL
was removed by gel filtration chromatography.
The concentrations of spin-labeled samples were
30–100 mM cpSRP43, at least 10-fold higher than
the apparent Kd of cysless cpSRP43 for 54 M
(0.39 mM)38 and LHCP (2–3 mM).34 After formation
of the cpSRP43-LHCP complex, samples were
ultracentrifuged at 100,000 rpm for 30 minutes to
remove aggregated proteins. EPR spectra were
acquired using a 9.4-GHz (X-band) EMX EPR
spectrometer (Bruker) equipped with an ER
4119HS cavity at 20–23 C. 5–30 scans were accu-
mulated and averaged using microwave power of 5
mWwith modulation amplitude set at 1 gauss and a
magnetic field sweep width of 100 gauss. The cen-
tral linewidth of EPR spectra was the same at
microwave powers of 0.2 – 5 mW. Less than 2%
background labeling was observed; background
subtraction was therefore not necessary.HDX detected by mass spectrometry
Solution-phase amide HDX experiments were
carried out with a fully automated system (CTC
HTS PAL, LEAP Technologies, Carrboro, NC;
housed inside a 4 C cabinet) as described
previously with slight modifications.70 HDX of full-
length cpSRP43, cpSRP43(intein), and cpSRP43-
SBD was performed at 4 C in 50 mM KHEPES
(pH 8.0) and 200 mM NaCl using an automated
system described previously.70 All samples were
run at 10 mM. L18 and 54 M peptides were added
at a 1:1 molar ratio to cpSRP43. Briefly, protein
was incubated at 4 C in a D2O buffer for a range
of exchange times (0 s, 10 s, 30 s, 60 s, 900 s,
and 3600 s) before quenching the exchange reac-
tion with an acidic quench solution (pH 2.4) contain-
ing 3 M urea and 1% TFA. All mixing and pepsin
digestions were carried out on a LEAP Technolo-
gies Twin HTS PAL liquid handling robot housed
inside a temperature controlled fridge. Protein
digestion was performed in-line with chromatogra-
phy using an immobilized pepsin column. Mass
spectra were acquired on a Q Exactive hybrid
quadrupole-Orbitrap mass spectrometer (Thermo-
Fisher Scientific).13Peptides were identified using tandem MS/MS
experiments performed with QExactive (Thermo
Fisher Scientific, San Jose, CA) over a 70 min
linear gradient. Product ion spectra were acquired
in a data-dependent mode and the five most
abundant ions were selected for the product ion
analysis per scan event. The MS/MS*.raw data
files were converted to *.mgf files and then
submitted to MASCOT (version 2.3 Matrix
Science, London, UK) for peptide identification.71
The maximum number of missed cleavages was
set at 4 with the mass tolerance for precursor ions
±0.6 Da and for fragment ions ±8 ppm. Oxidation to
methionine was selected for variable modification.
Pepsin was used for digestion and no specific
enzyme was selected in the MASCOT during the
search. Peptides included in the peptide set used
for HDX detection had a MASCOT score of 20 or
greater. The MS/MS MASCOT search was also
performed against a decoy (reverse) sequence
and false positives were ruled out if they did not
pass a 1% false discovery rate. The MS/MS spec-
tra of all the peptide ions from the MASCOT search
were further manually inspected, and only the
unique charged ions with the highest MASCOT
score were included in HDX peptide set.
HDX analyses were performed in triplicate, with
single preparations of each purified
protein/complex. The intensity weighted mean m/
z centroid value of each peptide envelope was
calculated and subsequently converted into a
percentage of deuterium incorporation. This is
accomplished determining the observed averages
of the undeuterated and fully deuterated spectra
and using the conventional formula described
elsewhere.72 Statistical significance for the differ-
ential HDX data is determined by an unpaired t-
test for each time point, and is integrated into the
HDX Workbench software.70,73
BTFA labeling and 19F NMR
Labeling reactions were performed in 50 mM
HEPES (pH 7.5), 200 mM NaCl. 200 mM
concentrations of reduced and degassed single
cysteine mutants of cpSRP43 were labeled with a
2 mM (tenfold molar excess) of BTFA (Sigma
Aldrich) at room temperature for 2 hours. Excess
BTFA was removed by two rounds of buffer
exchange into 50 mM sodium phosphate (pH
6.5), 150 mM NaCl then supplemented with 10%
D2O (NMR buffer). The final concentrations of
BTFA-labeled samples were 25–100 mM
cpSRP43. For urea titrations, samples were
buffer exchanged into NMR buffer supplemented
with either 0.5, 1, or 6 M urea. 1D 19F spectra
were acquired at 17 C on a Bruker Avance 600
spectrometer equipped with a 5 mm QCI
1H/19F/13C/15N quadruple resonance cryoprobe
with a single axis Z-gradient. 19F-DOSY
measurements were performed and used to
estimate the diffusion constant as described
A. Siegel, C.Z. McAvoy, V. Lam, et al. Journal of Molecular Biology 432 (2020) 166708previously.52 NMR data were processed with
NMRPipe.74 Peaks were analyzed in MestReNova
with peak deconvolutions fit to a generalized
Lorentzian using simulated annealing.751H-15N NMR spectroscopy
Multidimensional NMR spectra were recorded on
a Bruker Avance 800 spectrometer using a 5 mm
cryogenic TCI probe with a single Z-axis gradient,
and on an Avance 900 spectrometer using a
5 mm room temperature TXI probe with a triple
axis gradient. NMR spectra were acquired at
17 C using 2H, 15N-labeled protein (~0.2 mM) in
NMR buffer containing 10% (vol/vol) D2O at pH
6.5 or with low doses (0–0.4 M) of urea. NMR
data were processed with NMRPipe74 and ana-
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